Benjamin Reardon and Emmanuel J Favaloro/LinkedIn
Mar 16, 2026, 15:56
Emmanuel J. Favaloro: Latest Publication from Sydney Centres on Heparin Therapy and Monitoring
Emmanuel J. Favaloro, Lead Scientist at Sydney Centres for Thrombosis and Haemostasis, Westmead Hospital, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
“Latest publication from the Sydney Centres for Thrombosis and Haemostasis.
Heparin Anticoagulant Therapy and Its Monitoring.
Another review ably led by Benjamin Reardon.
Enjoy! ”
Title: Heparin Anticoagulant Therapy and Its Monitoring
Authors: Benjamin Reardon, Leonardo Pasalic, Giuseppe Lippi, Emmanuel J. Favaloro
Read the Full Article on Biomolecules.
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 5, 2026, 18:20Jessica Vega: How Listening to Patient Experience Reframes Warm Autoimmune Hemolytic Anemia Care
-
Nov 5, 2026, 18:15Paresh P Kulkarni: Frontiers in Immunology Launches Call for Papers on Innate Immune Mechanisms and Biomarkers in APS
-
Nov 5, 2026, 18:08Perrine Henry: Iliac Venous Thrombus Identified as Rare Cause of Hindlimb Lameness in Dog with Primary Erythrocytosis
-
Nov 5, 2026, 18:02Kellie Machlus: Bone Marrow Megakaryocytes Present Antigens and Regulate T Cells
-
Nov 5, 2026, 14:42Matteo Foschi: ASPERA-R Reveals the Challenges of Anticoagulation Resumption After Hemorrhagic Transformation
-
Nov 5, 2026, 14:30Khaled Musallam: Assessing the State of Thalassaemia and Sickle Cell Disease Care Across Europe
-
Nov 5, 2026, 14:17Joshua Muia: The Evolution of ADAMTS13 Research
-
Nov 5, 2026, 14:02Paulo Colimodio: Scientific Highlights from the XVII Argentine Congress of Hemostasis and Thrombosis
-
Nov 5, 2026, 13:52Emmanuel J Favaloro: STH Reports 2025 Impact Factor and Most Highly Cited Papers